Literature DB >> 9274833

Machado-Joseph disease gene products carrying different carboxyl termini.

J Goto1, M Watanabe, Y Ichikawa, S B Yee, N Ihara, K Endo, S Igarashi, Y Takiyama, C Gaspar, P Maciel, S Tsuji, G A Rouleau, I Kanazawa.   

Abstract

Three cDNA clones for the Machado-Joseph disease gene (MJD1) were isolated, two of which have a new exon sequence and a distinct 3' terminal nucleotide sequence resulting in a new carboxyl terminal domain in the translated product. The nucleotide sequence of the other one is similar to the previously published one except for five polymorphisms, one of which is a single nucleotide substitution resulting in a change from the stop codon (TAA; allele A) to a tyrosine residue (TAC; allele C). Genetic analysis results suggest that Japanese MJD mutations are associated with allele A.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274833     DOI: 10.1016/s0168-0102(97)00056-4

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  22 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

Authors:  Yuxin Mao; Francesca Senic-Matuglia; Pier Paolo Di Fiore; Simona Polo; Michael E Hodsdon; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 3.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

4.  Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study.

Authors:  C Gaspar; I Lopes-Cendes; S Hayes; J Goto; K Arvidsson; A Dias; I Silveira; P Maciel; P Coutinho; M Lima; Y X Zhou; B W Soong; M Watanabe; P Giunti; G Stevanin; O Riess; H Sasaki; M Hsieh; G A Nicholson; E Brunt; J J Higgins; M Lauritzen; L Tranebjaerg; V Volpini; N Wood; L Ranum; S Tsuji; A Brice; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  2000-12-20       Impact factor: 11.025

Review 5.  Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Veronica F Colomer Gould
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

6.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

7.  Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.

Authors:  Ginny Marie Harris; Katerina Dodelzon; Lijie Gong; Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

9.  Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene.

Authors:  Maria do Carmo Costa; Joana Gomes-da-Silva; Carlos J Miranda; Jorge Sequeiros; Manuela M Santos; Patrícia Maciel
Journal:  Genomics       Date:  2004-08       Impact factor: 5.736

10.  Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Katiuska Luna-Cancalon; Svetlana Fischer; Naila S Ashraf; Michelle Ouyang; Rahil M Dharia; Lucas Martin-Fishman; Yemen Yang; Vikram G Shakkottai; Beverly L Davidson; Edgardo Rodríguez-Lebrón; Henry L Paulson
Journal:  Mol Ther       Date:  2013-06-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.